Lensar (LNSR) Cash from Investing Activities (2019 - 2026)

Lensar's (LNSR) quarterly Cash from Investing Activities came in at $4.0 million in Q1 2026, up 653.3% year-on-year from $531000.0 in Q1 2025, and down 5.77% on a QoQ basis from $4.2 million in Q4 2025.

Lensar (LNSR) Cash from Investing Activities (2019 - 2026) Analysis & Trends

Lensar (LNSR) has 8 years of Cash from Investing Activities data on file, last reported at $4.0 million in Q1 2026.

  • On a quarterly basis, Cash from Investing Activities rose 653.3% year-over-year to $4.0 million in Q1 2026; TTM through Mar 2026 was $4.8 million, a 1276.49% increase from a year earlier, with the FY2025 full-year figure at $1.3 million, up 159.42% from the prior year.
  • Cash from Investing Activities for Q1 2026 stood at $4.0 million, down from $4.2 million in the prior quarter.
  • Over the last five years, Cash from Investing Activities for LNSR reached as high as $4.2 million in Q4 2025 and fell as low as -$7.5 million in Q2 2025.
  • Historically, Cash from Investing Activities has averaged -$67529.4 across 5 years, with a median of -$10000.0 in 2022.
  • Across the five-year window, Cash from Investing Activities sank 45150.0% in 2024 and surged 653.3% in 2026, its largest moves.
  • Year by year, Cash from Investing Activities stood at -$57000.0 in 2022, then tumbled by 6856.14% to -$4.0 million in 2023, then surged by 150.24% to $2.0 million in 2024, then jumped by 113.1% to $4.2 million in 2025, then fell by 5.77% to $4.0 million in 2026.
  • Per Business Quant data, the three most recent Cash from Investing Activities figures were $4.0 million in Q1 2026, $4.2 million in Q4 2025, and $4.0 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Abbott Laboratories 182.32 Bn 175.02 Bn 6.27 Bn -20.32 Bn
2 Stryker 128.75 Bn 125.88 Bn 3.81 Bn -185.00 Mn
3 Medtronic 107.83 Bn 98.61 Bn 6.41 Bn -917.00 Mn
4 Boston Scientific 67.61 Bn 66.15 Bn 3.61 Bn -591.00 Mn
5 Edwards Lifesciences 48.13 Bn 44.45 Bn 1.29 Bn -92.80 Mn
6 Dexcom 28.26 Bn 27.14 Bn 750.30 Mn -298.50 Mn
7 GE HealthCare Technologies 27.78 Bn 25.50 Bn 1.98 Bn -2.50 Bn
8 Smith & Nephew 26.99 Bn 26.41 Bn - -
9 Koninklijke Philips 23.92 Bn 20.80 Bn 2.07 Bn -475.32 Mn
10 Lensar 65.43 Mn 54.33 Mn 6.38 Mn 4.00 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 4.00 Mn
Mar 31, 2026 4.00 Mn
Dec 31, 2025 4.25 Mn
Dec 31, 2025 4.25 Mn
Sep 30, 2025 4.00 Mn
Sep 30, 2025 4.00 Mn
Jun 30, 2025 -7.49 Mn
Jun 30, 2025 -7.49 Mn
Mar 31, 2025 531,000.00
Mar 31, 2025 531,000.00
Dec 31, 2024 1.99 Mn
Dec 31, 2024 1.99 Mn
Sep 30, 2024 -905,000.00
Sep 30, 2024 -905,000.00
Jun 30, 2024 -2.02 Mn
Jun 30, 2024 -2.02 Mn
Mar 31, 2024 -1.23 Mn
Mar 31, 2024 -1.23 Mn
Dec 31, 2023 -3.97 Mn
Dec 31, 2023 -3.97 Mn